Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate, commonly known as Levofloxacin Ethyl Ester or Levofloxacin Cyclization Ester, is a key chiral intermediate in the synthesis of the broad-spectrum fluoroquinolone antibiotic, Levofloxacin. Its structure features a fused pyridobenzoxazine core with two fluorine atoms and a chiral center at the 3-methyl position, which is crucial for the biological activity of the final API. This compound is specifically designed and used in the final stages of the synthetic route to produce the active pharmaceutical ingredient (API) Levofloxacin. It undergoes hydrolysis and other transformations to yield the final carboxylic acid form of the drug. As a critical intermediate, its purity and stereochemical integrity are paramount for ensuring the efficacy and safety of the manufactured antibiotic. The primary industrial application of this ester is exclusively within the pharmaceutical sector for the production of Levofloxacin, which is used to treat various bacterial infections including respiratory, skin, and urinary tract infections. Its role is highly specialized, and it is not considered a general-purpose synthetic building block for other applications.